Taiwan researchers successfully imitate small compounds of experimental antiviral drug

Taiwan News
Date: 2020/02/20
By: Ching-Tse Cheng, Taiwan News, Staff Writer

TAIPEI (Taiwan News) — Taiwan's National Health Research Institutes (NHRI) said Thursday (Feb. 20) that researchers have successfully recreated small compounds of remdesivir and the country will likely be able to produce the American antiviral drug in the next few weeks.

During a progress report to Taiwan President Tsai Ing-wen (蔡英文), the NHRI Vice President Huey-Kang Sytwu (司徒惠康) pointed out that researchers have managed to develop milligrams of remdesivir, a drug which has shown promising results in Wuhan coronavirus (COVID-19) patients. He expects that the trial level can be upgraded within the next two weeks, potentially enabling Taiwan to produce its own remdesivir soon.    [FULL  STORY]